Report summary

Notifier

Name of person with notification obligation

BioInvest Aps

Reason for notification

Closely associated

Yes

Person discharging managerial responsibilities

Thomas Jonassen

Position

Member of the Board of Directors

Initial notification

Yes

Amendment

Details of amendment

Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor

Name of issuer

SynAct Pharma AB

Issuer´s LEI code

549300RRYIEFEQ72N546

Details of transaction

Type of financial instrument	Financial instrument	ISIN code	Nature of transaction	Linked to the exercise of a share option programme	Volume	Unit	Price per unit	Currency code	Transaction date	Place of the transaction
Share	SynAct Pharma AB	SE0008241491	Demerger decrease		3,531,644	Quantity	6.25	SEK	09/11/2023	Outside a trading venue

Aggregation

Financial instrument	ISIN code	Nature of transaction	Transaction date	Place of the transaction	Volume	Weighted average price
SynAct Pharma AB	SE0008241491	Demerger decrease	09/11/2023	Outside a trading venue	3,531,644 (Quantity)	6.25 SEK
				Total:	3,531,644

<< Back